Poland· PL-100463673
Gaviscon duo tab o smaku owoców leśnych
A alginic acid product containing natrii alginas + natrii hydrogenocarbonas + calcii carbonas, registered in Poland by Reckitt Benckiser (Poland) S.A.. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Alginic acid is registered in 10 of 19 countries.
Countries holding a registration under ATC A02BX13 (alginic acid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Alginic acid · ATC A02BX13
10 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Natrii alginas + Natrii hydrogenocarbonas + Calcii carbonas
- Manufacturer
- Reckitt Benckiser (Poland) S.A.
- Country
- Poland (PL)
- ATC code
- A02BX13
- ATC class
- Alginic acid
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909991526795
- gtin05909991526757
- gtin05909991526788
- gtin05909991526764
- gtin05909991526771
- gtin05909991526801
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alginic acid in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsGaviscon 250 mg aardbei, kauwtablettenReckitt Benckiser Healthcare B.V.
- SwitzerlandGaviscon Erdbeer, KautablettenReckitt Benckiser (Switzerland) AG
- SpainGAVISCON COMPRIMIDOS MASTICABLES SABOR FRESAReckitt Benckiser Healthcare S.A.
- FranceGAVINIUM MENTHE SANS SUCRE, comprimé à croquer édulcoré à l’aspartam et à l’acésulfame potassiqueRECKITT BENCKISER HEALTHCARE FRANCE
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1e0e467-f3ed-438f-85d1-a7de5fa6315c GET /v1/drugs/f1e0e467-f3ed-438f-85d1-a7de5fa6315c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki do rozgryzania i żucia",
"source": "urpl",
"strength": "250 mg + 106,5 mg + 187,5 mg",
"packaging": "05909991526757 ¦ OTC ¦ 152138\n12 tabl.\n05909991526788 ¦ OTC ¦ 152147\n16 tabl.\n05909991526764 ¦ OTC ¦ 152148\n24 tabl.\n05909991526771 ¦ OTC ¦ 152149\n32 tabl.\n05909991526795 ¦ OTC ¦ 152150\n48 tabl.\n05909991526801 ¦ OTC ¦ 152151\n60 tabl.",
"substance": "Natrii alginas 250 mg + Natrii hydrogenocarbonas 106.5 mg + Calcii carbonas 187.5 mg",
"common_name": "Natrii alginas + Natrii hydrogenocarbonas + Calcii carbonas",
"pl_product_id": "100463673",
"pozwolenie_nr": "28134",
"auth_procedure": "DCP",
"authorisation_validity": "2028-11-24"
}See everything about alginic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.